Joined Health Research Institute
- BSc, Experimental Psychology, State University of New York (Purchase, NY)
- PhD, Physical Chemistry, Stony Brook University (Stony Brook, NY)
- Research Fellow, Radiology, Stony Brook University Hospital (Stony Brook, NY)
Appointments and Affiliations
- Research Chair, Lakehead University/ Thunder Bay Regional Health Research Institute
- Professor of Chemistry, Lakehead University
- Adjunct Professor of Biology, Biotechnology, Health Sciences, and Physics, Lakehead University
- Adjunct Professor of Medical Sciences, Northern Ontario School of Medicine
- Scientist, TBRHRI
- Director of MRI Research, University of Massachusetts Medical School, Worcester, MA (2006-2011)
- Professor of Radiology, University of Massachusetts Medical School, Worcester, MA (2006-2011)
- Associate Professor of Radiology, Harvard Medical School, Boston, MA (2004-2006)
- Assistant Professor of Radiology, Harvard Medical School, Boston, MA (1998-2004)
- Instructor in Radiology, Harvard Medical School, Boston, MA (1995-1997)
- Instructor of Research in Radiology, Stony Brook University Hospital, Stony Brook, NY (1994-1995)
Dr. Mitchell Albert, PhD
Lakehead University/Thunder Bay Regional Health Research Institute Research Chair
Using Hyperpolarized (HP) Noble and Inert Fluorinated Gas Magnetic Resonance Imaging (MRI) for Structural and Functional Imaging
Dr. Mitchell Albert, who co-invented HP gas MRI as a diagnostic imaging technique in the 1990s, has been researching medical applications ever since. While a graduate student at Stony Brook University, he demonstrated the first ever HP Xenon (129Xe) MRI of mouse lungs, providing proof of concept as a new imaging method. He joined the Harvard Medical School in 1995 before becoming a professor and Director of MRI Research at the University of Massachusetts Medical School.
Dr. Albert is developing diagnostic tools at the Health Research Institute using HP Helium (3He) and 129Xe MRI as well as inert fluorinated gas MRI. These tools have the potential to provide more information on structure and function in the body. Some examples of applications could potentially be diagnosis and monitoring treatment of lung diseases such as COPD, HP 129Xe MRI brain imaging after a stroke, brain injury using xenon bio-sensors in living animals, and imaging cancer tumours using specific anti-tumour antibodies. Dr. Alberts research team is currently conducting a clinical trial in which HP 129Xe MRI technology is being used to obtain functional MR images from healthy volunteers and volunteers with Alzheimer’s disease.
Dr. Albert received the 1999 Presidential Early Career Award for Scientists and Engineers (PECASE) from President Clinton, and the United States’ National Science Foundation (NSF) Career Award in 2001 for his work with HP gas MRI.